About Forest Laboratories
Forest Laboratories is a company based in New York (United States) founded in 1954 was acquired by Actavis in February 2014. Forest Laboratories has completed 1 acquisition, including Cerexa.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Forest Laboratories
Detailed funding history for Forest Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Forest Laboratories
Forest Laboratories has secured backing from 1 investor. Prominent investors backing the company include Actavis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of generic products
|
Locked | Locked | Locked |
Investor details for Forest Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Forest Laboratories
Forest Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cerexa.
Investment portfolio details for Forest Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Hospital-based anti-infective therapies for antibiotic-resistant infections are developed.
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Forest Laboratories
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Forest Laboratories
Detailed financials for Forest Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Forest Laboratories Comparisons
Peer comparison for Forest Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Forest Laboratories
Detailed competitors of Forest Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Forest Laboratories
Complete news archive for Forest Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Forest Laboratories
Forest Laboratories was founded in 1954.
Forest Laboratories is headquartered in New York, United States. It is registered at New York, New York, United States.
Forest Laboratories was founded in 1954 and is headquartered in New York, United States. Operations focus on the pharmaceutical sector, where formulations are developed and marketed, particularly in central nervous system and cardiovascular therapeutic areas. A pipeline of product candidates spans various development stages and therapeutic fields. Key marketed brands include Bystolic, Daliresp, Fetzima, Linzess, Namenda, Saphris, Savella, Teflaro, Tudorza Pressair, and Viibryd.
Forest Laboratories has made 1 acquisition, including Cerexa.
Forest Laboratories has 1 investor. Key investors include Actavis.